Blood flow restriction mobilization for prevention of acquired weakness

Not Applicable

• Conditions: Muscle Weakness

• Registration Number: RBR-6yqjpv6
• Lead Sponsor: niversidade Estadual do Piauí - UESPI

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-09-21
• Last Update Posted: 16 October 2023
• Study Completion: 2025-03-30

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Adults over 18 years old. Both genders. Hospitalization for more than 24 hours in the ICU ward. The stay must be at least 72 hours

Exclusion Criteria

Neuromuscular pathology. Osteoarticular contraindication to mobilization. Amputees. Pregnant women

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction of acquired muscle weakness in critical patients; as well as the identification of the role of blood flow restriction therapy in preventing muscle weakness in critical patients.<br>

Secondary Outcome Measures

Name	Time	Method
Evaluation of the safety and feasibility of blood flow restriction therapy in critical patients, thus contributing to the production of scientific evidence in the field of early mobilization in critical patients.